Randy J. McBeath
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Randy J. McBeath
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics.
6
| Extinct | Pharmaceuticals: Major | 6 |
Mallinckrodt Medical, Inc.
 Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Mallinckrodt Medical, Inc. manufactures and markets healthcare products. Its products include contrast media & delivery systems, radiology imaging products, radiopharmaceuticals and urology imaging systems. The company is headquartered in Pointe-Claire, Canada.
5
| Subsidiary | Medical Specialties | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Randy J. McBeath tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Corporate Officer/Principal General Counsel | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TITAN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | General Counsel | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Investor Relations Contact | |
2941881 Canada, Inc.
 2941881 Canada, Inc. Medical SpecialtiesHealth Technology 2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada. | Medical Specialties | Director/Board Member | |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director of Finance/CFO | |
| AURA BIOSCIENCES, INC. | Biotechnology | Chief Operating Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Concordia University | College/University | Undergraduate Degree | |
| Golden Gate University | College/University | Masters Business Admin | |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of California, Berkeley | College/University | Graduate Degree | |
| University of California San Diego | College/University | Doctorate Degree | |
| University of South Alabama | College/University | Undergraduate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Diatide, Inc.
 Diatide, Inc. Pharmaceuticals: GenericHealth Technology Diatide, Inc. is a company based in Londonderry, NH. Diatide, Inc. was founded by André L. Lamotte. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Aerogen Ltd.
 Aerogen Ltd. Medical SpecialtiesHealth Technology Aerogen Ltd. develops and manufactures aerosol products. It offers Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-X controller and USB controller. The company was founded by John S. Power in 1997 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Investor Relations Contact | |
| Kendall Healthcare Products | Corporate Officer/Principal | ||
| EPIZYME, INC. | Biotechnology | General Counsel | |
Xanitos, Inc.
 Xanitos, Inc. Miscellaneous Commercial ServicesCommercial Services Xanitos, Inc. provides hospital housekeeping services. It services include employee training, quality assurance, work loading, laundry management, linen distribution, and patient transport. The company was founded by Graeme A. Crothall in 2008 and is headquartered in Newtown Square, PA. | Miscellaneous Commercial Services | Sales & Marketing | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Berlex Laboratories, Inc. | General Counsel | ||
| PREMIER, INC. | Hospital/Nursing Management | Sales & Marketing | |
Multiple Myeloma Canada
 Multiple Myeloma Canada Miscellaneous Commercial ServicesCommercial Services Multiple Myeloma Canada engages in the clinical research. It focuses on myeloma, a cancer of the plasma cells found in the bone marrow. The company was founded by Aldo Del Col in 2005 and is headquartered in Dorval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | General Counsel | |
| University of Wisconsin Parkside | College/University | Undergraduate Degree | |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
| ODONATE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | General Counsel | |
| Golden Gate Bioventures LLC | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 38 |
| Canada | 10 |
| Irlanda | 2 |
| Francia | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 35 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Technology Services | 2 |
| Health Services | 2 |
Posizioni
| Corporate Officer/Principal | 32 |
| Director/Board Member | 18 |
| General Counsel | 13 |
| Undergraduate Degree | 11 |
| Investor Relations Contact | 9 |
Contatti più connessi
| Insiders | |
|---|---|
| Mark P. Backer | 14 |
| Sylvia R. Wheeler | 14 |
| Steven Gannon | 14 |
| Mark de Rosch | 12 |
| Jeanne Jew | 11 |
| Carmen Betancourt | 11 |
| Robert G. Moussa | 10 |
| Peter J. Langecker | 9 |
| David W. Froesel | 8 |
| Stewart M. Kroll | 7 |
| George McNellage | 6 |
- Borsa valori
- Insiders
- Randy J. McBeath
- Connessioni Società
